Cambridge Nutritional SciencesFRA:RVKA Net Current Asset Value is €0.02 as of Sep. 2025, which is 100% below its 10-year median of 3.70. The stock has 3 warning signs investors should review. Among 569 Medical Devices & Instruments companies, Cambridge Nutritional Sciences ranks better than 96.31% on this metric.
In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).
The historical rank and industry rank for Cambridge Nutritional Sciences's Net Current Asset Value or its related term are showing as below:
FRA:RVKA'
s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 0.7 Med: 3.7 Max: 45
Current: 0.7
During the past 13 years, the highest Price-to-Net-Current-Asset-Value Ratio of Cambridge Nutritional Sciences was 45.00. The lowest was 0.70. And the median was 3.70.
FRA:RVKA's Price-to-Net-Current-Asset-Value is ranked better than 96.31% of 569
companies
in the Medical Devices & Instruments industry
Industry Median: 4.99
vs FRA:RVKA: 0.70
Cambridge Nutritional Sciences (FRA:RVKA) Net Current Asset Value Explanation
Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."
The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]
Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.
One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Grahams strategy produced similar results.
Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.
Cambridge Nutritional Sciences Net Current Asset Value Related Terms
Cambridge Nutritional Sciences Net Current Asset Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cambridge Nutritional Sciences Net Current Asset Value Chart
FRA:RVKA vs ISRG, BDX, MDLN: Net Current Asset Value Comparison
For the Medical Instruments & Supplies subindustry, Cambridge Nutritional Sciences's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cambridge Nutritional Sciences Price-to-Net-Current-Asset-Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Cambridge Nutritional Sciences's Price-to-Net-Current-Asset-Value distribution charts can be found below:
* The bar in red indicates where Cambridge Nutritional Sciences's Price-to-Net-Current-Asset-Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Net Current Asset Value of €0.02 mean?
Cambridge Nutritional Sciences (FRA:RVKA) has a Net Current Asset Value of €0.02 as of Sep. 2025. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Cambridge Nutritional Sciences and its competitors. This is 99% below median its historical median of 3.70. Over the past decade, Cambridge Nutritional Sciences' Net Current Asset Value has ranged from 0.70 to 45.00. According to the industry distribution chart, Cambridge Nutritional Sciences ranks #21 out of 569 companies in the Medical Devices & Instruments industry, placing it in the top 3.7%.
Is Cambridge Nutritional Sciences' Net Current Asset Value too high?
Cambridge Nutritional Sciences' current Net Current Asset Value of €0.02 is 99% below median its 10-year median of 3.70. Over the past 10 years, this metric has ranged from a low of 0.70 to a high of 45.00. Based on the distribution chart, Cambridge Nutritional Sciences ranks #21 out of 569 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers.
How does Cambridge Nutritional Sciences' Net Current Asset Value compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Cambridge Nutritional Sciences ranks #21 out of 569 companies for Net Current Asset Value. This places Cambridge Nutritional Sciences in the top 4% of its industry — outperforming the majority of peers. The industry median Net Current Asset Value is 4.99. Historically, Cambridge Nutritional Sciences' own Net Current Asset Value has ranged from 0.70 to 45.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for a Medical Devices & Instruments company?
The median Net Current Asset Value among Medical Devices & Instruments companies is 4.99, based on 569 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Cambridge Nutritional Sciences and its competitors. For the Medical Devices & Instruments industry, the median Net Current Asset Value is 4.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cambridge Nutritional Sciences's current Net Current Asset Value is €0.02, which is 99% below median its own 10-year median of 3.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cambridge Nutritional Sciences stock overvalued right now?
Cambridge Nutritional Sciences (FRA:RVKA) has a current Net Current Asset Value of €0.02. The stock's GF Value™ is €0.02, compared to a current price of €0.01 — trading 30% below its estimated fair value. The current Net Current Asset Value is €0.02, which is 99% below median its 10-year median of 3.70. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For Cambridge Nutritional Sciences (FRA:RVKA), the current Net Current Asset Value is €0.02 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cambridge Nutritional Sciences Business Description
Cambridge Nutritional Sciences PLC is a medical diagnostics company specializing in the development, manufacture, and distribution of food sensitivity test kits. Its product portfolio includes tests designed to detect immune reactions to various foods, helping healthcare professionals and patients identify dietary and lifestyle changes to improve long-term health and wellbeing. The company operates in the United Kingdom and serves the customer base across various countries through laboratories and healthcare providers. It generates revenue by selling diagnostic kits and providing clinical analysis services centered on food sensitivity and gut health. The group has two reportable segments: Health and Nutrition; and Corporate. The Health and Nutrition segment generates majority revenue.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:RVKA has been successfully added to your 